Last month, psychedelic drug developer MindMed scored an FDA breakthrough therapy designation for its LSD-D-tartrate candidate (MM120) in the treatment of generalised anxiety disorder (GAD). The company
Share this article Trelegy Ellipta is approved as a maintenance treatment for COPD and asthma in the US. Image Credit: MAXSHOT.PL / Shutterstock. Singapore’s Health
World Health Day 2024.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
In a decision that surprised Wall Street analysts, Teladoc Health announced that long-time CEO Jason Gorevic will depart the company immediately. In a statement, the
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! Meghana here. Today,
The cost of insulin in the United States has risen considerably in recent years, with some estimates finding that Americans have paid around 10 times
Share this article Amylyx’ ALS candidate Relyvrio has been taken off the market following a Phase III trial that missed its endpoints. Credit: MacroEcon via
Meet S.A.R.A.H.: A Smart AI Resource Assistant for Health What You Should Know: – The World Health Organization (WHO) unveils S.A.R.A.H., an AI-powered digital health